These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 18614924)

  • 21. Insulin-like growth factor-I (IGF-I), insulin-like growth factor binding proteins (IGFBP) and insulin-like growth factor type I receptor in children with various status of chronic renal failure.
    Houang M; Cabrol S; Perin L; Ducos B; Bensman A; Le Bouc Y
    Growth Horm IGF Res; 2000 Dec; 10(6):332-41. PubMed ID: 11161964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin-like growth factor I, its binding proteins 1 and 3, and growth hormone-binding protein in children and adolescents with insulin-dependent diabetes mellitus: clinical implications.
    Muñoz MT; Barrios V; Pozo J; Argente J
    Pediatr Res; 1996 Jun; 39(6):992-8. PubMed ID: 8725260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between insulin-like growth factors (IGF-I and IGF-II), IGF-binding proteins (IGFBP-3, IGFBP-2), leptin and anthropometric parameters (height, body mass index) during antileukaemic treatment in children.
    Krawczuk-Rybak M; Muszyńska-Rosłan K; Kitszel A; Sawicka-Zukowska M; Wołczyński S
    Rocz Akad Med Bialymst; 2005; 50():208-11. PubMed ID: 16358968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures.
    Benbassat CA; Maki KC; Unterman TG
    J Clin Endocrinol Metab; 1997 May; 82(5):1484-91. PubMed ID: 9141538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The circulating insulin-like growth factor system in children with coeliac disease: an additional marker for disease activity.
    Locuratolo N; Pugliese G; Pricci F; Romeo G; Mariani P; Diaz-Horta O; Calvani L; Montuori M; Cipolletta E; Di Mario U; Bonamico M
    Diabetes Metab Res Rev; 1999; 15(4):254-60. PubMed ID: 10495474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of the outcome of growth hormone provocative testing in short children by measurement of serum levels of insulin-like growth factor I and insulin-like growth factor binding protein 3.
    Juul A; Skakkebaek NE
    J Pediatr; 1997 Feb; 130(2):197-204. PubMed ID: 9042120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in cystic fibrosis: a positive effect of antibiotic therapy and hyperalimentation.
    Lebl J; Zahradníková M; Bartosová J; Zemková D; Pechová M; Vávrová V
    Acta Paediatr; 2001 Aug; 90(8):868-72. PubMed ID: 11529532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin-like growth factor binding proteins in prepubertal children with insulin-dependent diabetes mellitus.
    Knip M; Tapanainen P; Pekonen F; Blum WF
    Eur J Endocrinol; 1995 Oct; 133(4):440-4. PubMed ID: 7581967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum levels of type I procollagen C-terminal propeptide, insulin-like growth factor-I (IGF-I), and IGF binding protein-3 in obese children and adolescents: relationship to gender, pubertal development, growth, insulin, and nutritional status.
    Falorni A; Bini V; Cabiati G; Papi F; Arzano S; Celi F; Sanasi M
    Metabolism; 1997 Aug; 46(8):862-71. PubMed ID: 9258266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum concentrations of insulin, insulin-like growth factor(IGF)-I, IGF binding protein (IGFBP)-1 and -3 and growth hormone binding protein in obese children: fasting IGFBP-1 is suppressed in normoinsulinaemic obese children.
    Saitoh H; Kamoda T; Nakahara S; Hirano T; Nakamura N
    Clin Endocrinol (Oxf); 1998 Apr; 48(4):487-92. PubMed ID: 9640416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
    Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Responsiveness of IGF-I and IGFBP-3 to therapeutic intervention in children and adolescents with Crohn's disease.
    Beattie RM; Camacho-Hübner C; Wacharasindhu S; Cotterill AM; Walker-Smith JA; Savage MO
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):483-9. PubMed ID: 9876346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relation between serum Insulin-like growth factor-I and insulin-like growth factor-binding protein-3 levels, clinical status and growth parameters in prepubertal cystic fibrosis patients.
    Ozen M; Cokugras H; Ozen N; Camcioglu Y; Akcakaya N
    Pediatr Int; 2004 Aug; 46(4):429-35. PubMed ID: 15310308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changed bone status in human immunodeficiency virus type 1 (HIV-1) perinatally infected children is related to low serum free IGF-I.
    Stagi S; Bindi G; Galluzzi F; Galli L; Salti R; de Martino M
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):692-9. PubMed ID: 15579182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The endocrine consequences for very low birth weight premature infants.
    Cutfield WS; Regan FA; Jackson WE; Jefferies CA; Robinson EM; Harris M; Hofman PL
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S130-5. PubMed ID: 15135795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin-like growth factor system in patients with HIV infection: effect of exogenous growth hormone administration.
    Mynarcik DC; Frost RA; Lang CH; DeCristofaro K; McNurlan MA; Garlick PJ; Steigbigel RT; Fuhrer J; Ahnn S; Gelato MC
    J Acquir Immune Defic Syndr; 1999 Sep; 22(1):49-55. PubMed ID: 10534146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IGF-I, IGF binding protein (IGFBP)-3, phosphoisoforms of IGFBP-1, and postnatal growth in very low birth weight infants.
    Kajantie E; Dunkel L; Rutanen EM; Seppälä M; Koistinen R; Sarnesto A; Andersson S
    J Clin Endocrinol Metab; 2002 May; 87(5):2171-9. PubMed ID: 11994360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum IGF-1 and IGFBP-3 levels in healthy children between 0 and 6 years of age.
    Yüksel B; Özbek MN; Mungan NÖ; Darendeliler F; Budan B; Bideci A; Çetinkaya E; Berberoğlu M; Evliyaoğlu O; Yeşilkaya E; Arslanoğlu İ; Darcan Ş; Bundak R; Ercan O
    J Clin Res Pediatr Endocrinol; 2011; 3(2):84-8. PubMed ID: 21750637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of economic status on height, insulin-like growth factor (IGF)-I and IGF binding protein-3 concentrations in healthy Turkish children.
    Turan S; Bereket A; Furman A; Omar A; Berber M; Ozen A; Akbenlioglu C; Haklar G
    Eur J Clin Nutr; 2007 Jun; 61(6):752-8. PubMed ID: 17164829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation.
    Juul A; Dalgaard P; Blum WF; Bang P; Hall K; Michaelsen KF; Müller J; Skakkebaek NE
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2534-42. PubMed ID: 7543116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.